dc.contributor.author |
Nucci, Marcio |
|
dc.contributor.author |
Queiroz-Telles, Flavio |
|
dc.contributor.author |
Alvarado-Matute, Tito |
|
dc.contributor.author |
Tiraboschi, Iris Nora |
|
dc.contributor.author |
Cortes, Jorge |
|
dc.contributor.author |
Zurita, Jeannete |
|
dc.contributor.author |
Guzman-Blanco, Manuel |
|
dc.contributor.author |
Santolaya, Maria Elena |
|
dc.contributor.author |
Thompson, Luis |
|
dc.contributor.author |
Sifuentes-Osornio, Jose |
|
dc.contributor.author |
Echevarria Zarate, Juan Ignacio |
|
dc.contributor.author |
Colombo, Arnaldo L. |
|
dc.date.accessioned |
2022-01-04T20:31:48Z |
|
dc.date.available |
2022-01-04T20:31:48Z |
|
dc.date.issued |
2013 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/10679 |
|
dc.description.abstract |
Background: The epidemiology of candidemia varies depending on the geographic region. Little is known about the epidemiology of candidemia in Latin America. Methods: We conducted a 24-month laboratory-based survey of candidemia in 20 centers of seven Latin American countries. Incidence rates were calculated and the epidemiology of candidemia was characterized. Results: Among 672 episodes of candidemia, 297 (44.2%) occurred in children (23.7% younger than 1 year), 36.2% in adults between 19 and 60 years old and 19.6% in elderly patients. The overall incidence was 1.18 cases per 1,000 admissions, and varied across countries, with the highest incidence in Colombia and the lowest in Chile. Candida albicans (37.6%), C. parapsilosis (26.5%) and C. tropicalis (17.6%) were the leading agents, with great variability in species distribution in the different countries. Most isolates were highly susceptible to fluconazole, voriconazole, amphotericin B and anidulafungin. Fluconazole was the most frequent agent used as primary treatment (65.8%), and the overall 30-day survival was 59.3%. Conclusions: This first large epidemiologic study of candidemia in Latin America showed a high incidence of candidemia, high percentage of children, typical species distribution, with C. albicans, C. parapsilosis and C. tropicalis accounting for the majority of episodes, and low resistance rates. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS ONE |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Latin America |
en_US |
dc.subject |
major clinical study |
en_US |
dc.subject |
outcome assessment |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
disease association |
en_US |
dc.subject |
incidence |
en_US |
dc.subject |
prospective study |
en_US |
dc.subject |
South and Central America |
en_US |
dc.subject |
age distribution |
en_US |
dc.subject |
amphotericin B |
en_US |
dc.subject |
antifungal susceptibility |
en_US |
dc.subject |
Candida |
en_US |
dc.subject |
Candida albicans |
en_US |
dc.subject |
Candida glabrata |
en_US |
dc.subject |
Candida parapsilosis |
en_US |
dc.subject |
Candida tropicalis |
en_US |
dc.subject |
candidemia |
en_US |
dc.subject |
fluconazole |
en_US |
dc.subject |
Fluconazole |
en_US |
dc.subject |
fungus identification |
en_US |
dc.subject |
molecular epidemiology |
en_US |
dc.subject |
voriconazole |
en_US |
dc.subject |
Species Specificity |
en_US |
dc.subject |
Epidemiological Monitoring |
en_US |
dc.subject |
Candida krusei |
en_US |
dc.subject |
fungus isolation |
en_US |
dc.subject |
Candidemia |
en_US |
dc.subject |
survival rate |
en_US |
dc.subject |
anidulafungin |
en_US |
dc.subject |
Pichia guilliermondii |
en_US |
dc.subject |
survival time |
en_US |
dc.subject |
Statistics, Nonparametric |
en_US |
dc.subject |
organisms by geographical distribution |
en_US |
dc.subject |
species distribution |
en_US |
dc.title |
Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pone.0059373 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.09 |
|
dc.relation.issn |
1932-6203 |
|